Oric Pharmaceuticals earnings were -$135.2M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ORIC earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$35.8M, up 17.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ORIC reported annual earnings of -$129.5M, with 1.3% growth. The next ORIC earnings date is Aug 11, 2026.
Oric Pharmaceuticals Earnings Reports & History FAQ
What were Oric Pharmaceuticals's earnings last quarter?
On ORIC's earnings call on May 11, 2026, Oric Pharmaceuticals (NASDAQ: ORIC) reported Q1 2026 earnings per share (EPS) of -$0.34, up 19.05% year over year. Total ORIC earnings for the quarter were -$35.77 million. In the same quarter last year, Oric Pharmaceuticals's earnings per share (EPS) was -$0.42.
The next ORIC earnings date is Aug 11, 2026. Add ORIC to your watchlist to be reminded of Oric Pharmaceuticals's next earnings date.
Is Oric Pharmaceuticals profitable or losing money?
As of the last Oric Pharmaceuticals earnings report, Oric Pharmaceuticals is currently losing money. Oric Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$135.21 million, a 1.77% increase year over year.
What was ORIC's earnings growth in the past year?
As of Oric Pharmaceuticals's earnings date in May 11, 2026, Oric Pharmaceuticals's earnings has grown year over year. ORIC earnings in the past year totalled -$135.21 million.
What are Oric Pharmaceuticals's earnings expectations?
The current EPS estimate for Oric Pharmaceuticals's earnings report in Aug 11, 2026 is -$0.36.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.